EGFR and non-small cell lung carcinoma: The effects of lovastatin were largely rescued by cholesterol or mevalonate addition, but this rescue was absent when ERRα expression was downregulated by XCT790, suggesting that the sensitizing effect of lovastatin on NSCLC EGFR-TKIs resistant cells are ERRα-dependent in vitro (Fig. 6b, c).